Starting or Strengthening a Drug Bulletin - A Practical Manual
(2005; 165 pages) View the PDF document
Table of Contents
View the documentPreface
View the documentHow the manual was produced
View the documentAbout ISDB
View the documentExecutive summary
Close this folder1. Introduction
View the document1.1 Are you starting or developing a bulletin?
View the document1.2 Objectives of this manual
View the document1.3 The need for the manual
View the document1.4 The importance of feedback
Open this folder and view contents2. Rational use of medicines
Open this folder and view contents3. What are drug bulletins?
Open this folder and view contents4. Defining aims, target and type of bulletin
Open this folder and view contents5. Planning resources
Open this folder and view contents6. Planning bulletin production: schedules and timing
Open this folder and view contents7. The editorial process
Open this folder and view contents8. Reviewing a new drug: is it a therapeutic advance?
Open this folder and view contentsAnnexe to Chapter 8: Evaluating harm
Open this folder and view contents9. Design and production
Open this folder and view contents10. Dissemination
Open this folder and view contents11. Organizational and legal issues
Open this folder and view contents12. Evaluating quality and usefulness
Open this folder and view contents13. Partnership and collaboration
Open this folder and view contents14. Keeping records and creating a memory
Open this folder and view contentsAppendix: Electronic sources of information

1.3 The need for the manual

Those involved in prescribing and using drugs need access to information which will enable them to use drugs, when they are needed, in ways which maximise the potential benefits and minimise the risks. Independent drug bulletins provide valuable information in a summarised and readable form which can help those involved in decisions about drugs to make those decisions wisely. The first few independent drug bulletins were established in the 1960s and the International Society of Drug Bulletins (ISDB) was founded in 1986.

Over the last 20 years many new drug bulletins have been established both in developing and industrialised countries and in the Newly Independent States. Many of these new bulletins have received advice and support from existing bulletins and from ISDB. In addition, ISDB has organized several training schools and regional meetings at which participants exchange experiences and develop the skills necessary to develop and run a quality drug bulletin (see Apart from these training schools and the informal contacts between members there have been few opportunities to share experiences and there is a lack of written information about the specific work of drug bulletins. This has made it difficult for those involved in new bulletins to benefit from the work of others. Often they have to discover for themselves the methods and procedures which have already been tried and tested by others. Unnecessary duplication of effort wastes time and resources. Sharing skills and experiences not only reduces this waste but it also contributes to the development of high quality bulletins and to a shared philosophy and common understanding of goals. Working together is one way of maintaining both quality and commitment. This manual is produced as a result of collaboration, and should strengthen future collaboration between bulletins.

to previous section
to next section
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 6, 2017